Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.

被引：0
|
作者：
Smith, Stephanie M.
Sabnis, Himalee S.
Lewis, Rebecca Williamson
Effinger, Karen Elizabeth
Bergsagel, Daniel John
Patterson, Briana
Mertens, Ann C.
Sakamoto, Kathleen
Schapira, Lidia
Castellino, Sharon M.
机构：
[1] Stanford Univ, Dept Pediat, Sch Med, Div Hematol Oncol, Stanford, CA 94305 USA
[2] Childrens Healthcare Atlanta, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[5] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[6] AFLAC Canc Ctr & Blood Disorders Svc, Atlanta, GA USA
[7] Emory Univ, Sch Med, Dept Pediat, Div Endocrinol, Atlanta, GA USA
[8] Stanford Univ, Stanford, CA 94305 USA
[9] Stanford Canc Inst, Stanford, CA USA
[10] Childrens Healthcare Atlanta, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22527
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A gene polymorphism within the kinase domain of BCR-ABL and its effects on sensitivity to tyrosine kinase inhibitors.
    Crossman, LC
    O'Hare, T
    Lange, T
    Willis, SG
    Stoffregen, EP
    Corbin, AS
    O'Brien, SG
    Heinrich, MC
    Druker, BJ
    Middleton, PG
    Deininger, MWN
    BLOOD, 2005, 106 (11) : 439A - 439A
  • [22] Screening assays for tyrosine kinase inhibitors: A review
    Gao, Juan
    Jian, Jingyi
    Jiang, Zhengjin
    Van Schepdael, Ann
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 223
  • [23] Screening of microbial extracts for tyrosine kinase inhibitors
    Alvi, KA
    Nair, B
    Gallo, C
    Baker, D
    JOURNAL OF ANTIBIOTICS, 1997, 50 (03): : 264 - 266
  • [24] A SYSTEMS BIOLOGY APPROACH TO PREDICTING CARDIOTOXICITY ASSOCIATED WITH TYROSINE KINASE INHIBITORS.
    Zaman, S.
    Gao, C.
    Abernethy, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S20 - S20
  • [25] A SYSTEMS BIOLOGY APPROACH TO PREDICTING CARDIOTOXICITY ASSOCIATED WITH TYROSINE KINASE INHIBITORS.
    Zaman, S.
    Gao, C.
    Abernethy, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S75 - S75
  • [26] A SYSTEMS BIOLOGY APPROACH TO PREDICTING CARDIOTOXICITY ASSOCIATED WITH TYROSINE KINASE INHIBITORS.
    Zaman, S.
    Gao, C.
    Abernethy, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S7 - S8
  • [27] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Ghatalia, Pooja
    Morgan, Charity
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia
    Toker, Michelle
    Jaller, Jose A.
    Delbourgo Patton, Caroline
    Wu, Benedict
    PEDIATRIC DERMATOLOGY, 2024, 41 (01) : 169 - 176
  • [29] TYROSINE KINASE INHIBITORS AND RENAL EFFECTS
    Turgut, Didem
    Yucel, Sebnem
    Bilgin, Burak
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 74 - 74
  • [30] Diverging acquired resistance evolutionary pathways in fusion-positive patients treated with tyrosine kinase inhibitors.
    Repetto, Matteo
    Selenica, Pier
    Gazzo, Andrea
    Richards, Allison L.
    Reis-Filho, Jorge S.
    Jee, Justin
    Donoghue, Mark
    Weigelt, Britta
    Drilon, Alexander E.
    Choudhury, Noura J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345